Small intestine bacterial overgrowth in patients with irritable bowel syndrome

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue 3, 2008, Pages 197-202

  Carrara, Maurizio ^a   Desideri, S ^a   Azzurro, M ^a   Bulighin, G M ^a   Di Piramo, D ^a   Lomonaco, L ^a   Adamo, S ^a  

^a Ospedale Orlandi   (Italy)

Author keywords

Irritable bowel syndrome; Lactulose breath test; Prevalence; Small intestine bacterial overgrowth

Indexed keywords

HYDROGEN; LACTULOSE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CONTAMINATION; BREATH ANALYSIS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; SMALL INTESTINE BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIA; FEMALE; HUMANS; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 48049108263     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. OBERNDORFF-KLEIN WOOLTHUIS AH, BRUMMER RJ, DE WIT NJ, MURIS JW, STOCKBRÜGGER RW. Irritable bowel syndrome in general practice: An overview. Scand J Gastroenterol Suppl 2004; 241: 17-22.
2. LONGSTRETH GF. Definition and classification of irritable bowel syndrome: Current consensus and controversies. Gastroenterol Clin North Am 2005; 34: 173-187.
3. POSSERUD J, ERSRYD A, SIMRÉN M. Functional findings in irritable bowel syndrome. World J Gastroenterol 2006; 12: 2830-2838.
4. SADLACK B, METZ H, SCHORLE H, SCHIMPL A, FELLER A, HORAK J. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253-261.
5. KÜHN R, LÖHLER J, RENNICK D, RAJEWSKI K, MÜLLER W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274.
6. VANNER S. The small intestinal bacterial overgrowth-irritable bowel syndrome hypothesis: Implications for treatment. Gut 2008 Feb 4 [Epub ahead of print].
7. ESPOSITO I, DE LEONE A, DI GREGORIO G, GIAQUINTO S, DE MAGISTRIS L, FERRIERI A, RIEGLER G. Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: An observation on non-absorbable antibiotics. World J Gastroenterol 2007; 13: 6016-6021.
8. Cuoco L, SALVAGNINI M. Small intestine bacterial overgrowth in irritable bowel syndrome: A retrospective study with rifaximin. Minerva Gastroenterol Dietol 2006; 52: 89-95.
9. MADRID AM, DEFILIPPI CC, DEFILIPPI GC, SLIMMING AJ, QUERA PR. Small intestinal bacterial overgrowth in patients with functional gastrointestinal diseases. Rev Med Chil 2007; 135: 1245-1252.
10. LIN HC, PIMENTEL M. Bacterial concepts in irritable bowel syndrome. Rev Gastroenterol Disord 2005; 5 (Suppl 3): S3-9.
11. PIMENTEL M, SOFFER EE, CHOW EJ, KONG Y, LIN HC. Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci 2002; 47: 2639-2643.
12. PIMENTEL M, MAYER AG, PARK S, CHOW EJ, HASAN A, KONG Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 2003; 48: 86-92.
13. PIMENTEL M, CHOW EJ, LIN HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503-3506.
14. PIMENTEL M, CHOW EJ, LIN HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome, a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98: 412-419.
15. WALTERS B, VANNER SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: Comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005; 100: 1566-1570.
16. GHOSHAL UC, GHOSHAL U, DAS K, MISRA A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 2006; 25: 6-10.
17. BONDARENKO VM, LYKOVA EA, MATSULEVICH TV. Microecological aspects of small intestinal bacterial overgrowth syndrome. Zh Mikrobiol Epidemiol Immunobiol 2006; 6: 57-63.
18. KING CE, TOSKES PP. Breath tests in the diagnosis of small intestine bacterial overgrowth. Crit Rev Clin Lab Sci 1984; 21: 269-281.
19. BAYELI PF, MARIOTTINI M, LISI L, FERRARI P, TEDONE F. Guidelines on intestinal dysmicrobism (SIBO Small Intestine Bacterial Overgrowth). Minerva Gastroenterol Dietol 1999; 45: 297-308.
20. DI STEFANO M, MICELI E, MISSANELLI A, CORAZZA GR. Treatment of small intestine bacterial overgrowth. Eur Rev Med Pharmacol Sci 2005; 9: 217-222.
21. CORAZZA GR, SORGE M, STROCCHI A, BENATI G, DI SARIO A, TREGGIARI EA, BRUSCO G, GASBARRINI G. Non-absorbable antibiotics and small bowel bacterial overgrowth. Ital J Gastroenterol 1992; 24: 4-9.
22. POLTER DE, BOYLE JD, MILLER LG, FINEGOLD SM. Anaerobic bacteria as cause of the blind loop syndrome. A case report with observations on response to antibacterial agents. Gastroenterology 1968; 54: 1148-1154.
23. FUMI AL, TREXLER K. Rifaximin treatment for symptoms of irritable bowel syndrome. Ann Pharmacother 2008 (in press).
24. MAJEWSKI M, MCCALLUM RW. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: Clinical profiles and effects of antibiotic trial. Adv Med Sci 2007; 52: 139-142.
25. LYKOVA EA, BONDARENKO VM, PARFENOV AI, MATSULEVICH TV. Bacterial overgrowth syndrome in the small intestine: Pathogenesis, clinical significance and therapy tactics. Eksp Klin Gastroenterol 2005; 6: 51-57, 113.